Global Cloud Service Brokerage Market Size Study & Forecasts, 2017-2025

Global Cloud Service Brokerage Market Size Study, By Service Type( Catalog Management, Workload Management, Operations Management, Integration), By Platform, By Deployment model(Public, Private), By Organization, By End User(ICT, BFSI, Healthcare, Public Sector, Energy, Retail) and Regional Forecasts, 2017-2025

For discount/customization and buying a particular chapter, write to us at sales@bizwitresearch.com

Global CRISPR market is valued approximately USD 248 million in 2015. The growth is primarily driven by the rising demand for drug discovery and a significant rise in research spending. Further, increasing prevalence of genetic disorders due to late pregnancies and changing lifestyle patterns have drawn the significant attention of the researchers towards this emerging technology. Global CRISPR Market report offers a detailed analysis of key factors impacting the market growth. Our report offers Global CRISPR Market Size & Forecasts for 2017-2025. Base year considered for market size estimations is 2016.     

The CRISPR technology has witnessed highest adoption in gene editing applications due to easy availability of gene editing tools and cost-effectiveness. Though the technology has restricted use due to some ethical issues, it is increasingly being used in some other applications of this technology include Genetic Engineering, Cell Line Engineering, and others. The total market revenue has been broadly segmented into application segment, end-user segment, and geography. Each of the segments in global CRISPR market report is further divided as follows:

Applications:

  • Genome Editing
  • Genetic Engineering
  • Gene Library
  • CRISPR Plasmid
  • Human Stem Cells
  • Genetically Modified Crops (GMO)
  • Cell Line Engineering

End User:

  • Biotechnology Companies
  • Pharmaceutical Companies
  • Academic Institutes
  • Research & Development Institutes

Regions:

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
  • Asia Pacific
    • China
    • India
    • Japan
  • Latin America
    • Brazil
    • Mexico
  • Rest of the World

Among end-user segment Biotechnology firms and Research & Development Institutes captures more than 60% of total revenue share in 2016. High investment from these end-user segments is the primary driving force for the adoption this emerging technology. Further, over the forecast period, Pharmaceutical firms are expected to witness highest growth rate. Significant developments in the field of pharmaceutical biotechnology are expected to generate huge opportunities over the coming eight years.   

The global CRISPR market is dominated by North America region followed by Asia Pacific. The rising prevalence of infertility and genetic disorders in the Asia Pacific region are the primary driving factors. Agriculture and Animal breeding are the emerging applications in the Asian countries. North America captures approximately 38% of the total revenue share in 2015. Europe is also an emerging region for the development of this technology which is likely to witness significant growth over the forecast period.

Some of the major players mentoined in global CRISPR market report are; Thermo Fisher Scientific, Editas Medicine, Caribou Biosciences, Inc., CRISPR Therapeutics A, Intellia Therapeutics, Inc., Cellectis, Horizon Discovery PLC, Sigma-Aldrich Corporation, Precision BioSciences, GenScript Corporation, Sangamo Therapeutics, Inc. (SGMO), Lonza Group Limited, Integrated DNA Technologies, New England Biolabs, OriGene Technologies, Inc,.Transposagen Biopharmaceuticals, Inc

Chapter 1.           Research Methodology

1.1.         Research Process

1.1.1.     Data Mining

1.1.2.     Analysis

1.1.3.     Market Estimation

1.1.4.     Validation

1.1.5.     Publishing

1.2.         Research Assumption

Chapter 2.           Global CRISPR Market Definition & Scope

2.1.         Objective of The Study

2.2.         Market Definition

2.3.         Scope of The Study

2.4.         Years Considered for The Study

2.5.         Currency Conversion Rates

2.6.         Report Limitation

Chapter 3.           Executive Summary

3.1.         Key Trends

3.2.         Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion/Million)

Chapter 4.           Global CRISPR Industry Dynamics

4.1.         Growth Prospects

4.1.1.     Drivers

4.1.2.     Restraints

4.1.3.     Opportunities

4.2.         Industry Analysis

4.3.         Porter’s 5 Force Model

4.4.         PEST Analysis

4.5.         Value Chain Analysis

4.6.         Analyst Recommendation & Conclusion

Chapter 5.           Global CRISPR Market by Application

5.1.         Market Snapshot

5.2.         CRISPR Market, Sub Segment Analysis

5.2.1.     Genome Editing

5.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

5.2.1.2. Regional breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

5.2.2.     Genetic Engineering

5.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

5.2.2.2. Regional breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

5.2.3.     Gene Library

5.2.3.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

5.2.3.2. Regional breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

5.2.4.     CRISPR Plasmid

5.2.4.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

5.2.4.2. Regional breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

5.2.5.     Human Stem Cells

5.2.5.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

5.2.5.2. Regional breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

5.2.6.     Genetically Modified Crops(GMO)

5.2.6.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

5.2.6.2. Regional breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

5.2.7.     Cell Line Engineering

5.2.7.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

5.2.7.2. Regional breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

Chapter 6.           Global CRISPR Market by End User

6.1.         Market Snapshot

6.2.         CRISPR Market, Sub Segment Analysis

6.2.1.     Biotechnology Companies

6.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

6.2.1.2. Regional breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

6.2.2.     Pharmaceutical Companies

6.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

6.2.2.2. Regional breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

6.2.3.     Academic Institutes

6.2.3.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

6.2.3.2. Regional breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

6.2.4.     Research & Development Institutes

6.2.4.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

6.2.4.2. Regional breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

Chapter 7.           Global CRISPR Market, Regional Analysis

7.1.         CRISPR Market, Regional Market Snapshot (2015-2025)

7.2.         North America CRISPR Market Snapshot

7.2.1.     U.S. CRISPR Market Size Estimates & Forecast, 2015-2025 (USD Billion/Million)

7.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

7.2.1.2. Application breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

7.2.1.3. End User breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

7.2.2.     Canada CRISPR Market Size Estimates & Forecast, 2015-2025 (USD Billion/Million)

7.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

7.2.2.2. Application breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

7.2.2.3. End User breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

7.3.         Europe CRISPR Market Snapshot

7.3.1.     U.K. CRISPR Market Size Estimates & Forecast, 2015-2025 (USD Billion/Million)

7.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

7.3.1.2. Application breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

7.3.1.3. End User breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

7.3.2.     Germany CRISPR Market Size Estimates & Forecast, 2015-2025 (USD Billion/Million)

7.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

7.3.2.2. Application breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

7.3.2.3. End User breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

7.3.3.     France CRISPR Market Size Estimates & Forecast, 2015-2025 (USD Billion/Million)

7.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

7.3.3.2. Application breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

7.3.3.3. End User breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

7.3.4.     Rest of Europe CRISPR Market Size Estimates & Forecast, 2015-2025 (USD Billion/Million)

7.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

7.3.4.2. Application breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

7.3.4.3. End User breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

7.4.         Asia CRISPR Market Snapshot

7.4.1.     China CRISPR Market Size Estimates & Forecast, 2015-2025 (USD Billion/Million)

7.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

7.4.1.2. Application breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

7.4.1.3. End User breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

7.4.2.     India CRISPR Market Size Estimates & Forecast, 2015-2025 (USD Billion/Million)

7.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

7.4.2.2. Application breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

7.4.2.3. End User breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

7.4.3.     Japan CRISPR Market Size Estimates & Forecast, 2015-2025 (USD Billion/Million)

7.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

7.4.3.2. Application breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

7.4.3.3. End User breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

7.4.4.     Rest of Asia Pacific CRISPR Market Size Estimates & Forecast, 2015-2025 (USD Billion/Million)

7.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

7.4.4.2. Application breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

7.4.4.3. End User breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

7.5.         Rest of The World CRISPR Market Snapshot

7.5.1. Market estimates & forecasts, 2015-2025 (USD Billion/Million)

7.5.2. Application breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

7.5.3. End User breakdown estimates and forecasts, 2015-2025 (USD Billion/Million)

Chapter 8.           Competitive Intelligence

8.1.         Company Market Share (Subject to Data Availability)

8.2.         Top Market Strategies

8.3.         Company Profiles

8.3.1.     Thermo Fisher Scientific

8.3.1.1. Overview

8.3.1.2. Financial (Subject to Data Availability)

8.3.1.3. Product Summary

8.3.1.4. Recent Developments

8.3.2.     Editas Medicine

8.3.3.     Caribou Biosciences, Inc.

8.3.4.     CRISPR Therapeutics AG

8.3.5.     Intellia Therapeutics, Inc.

8.3.6.     Cellectis

8.3.7.     Horizon Discovery PLC

8.3.8.     Sigma-Aldrich Corporation

8.3.9.     Precision BioSciences, Inc.

8.3.10.   GenScript Corporation

8.3.11.   Sangamo Therapeutics, Inc. (SGMO)

8.3.12.   Lonza Group Limited

8.3.13.   Integrated DNA Technologies

8.3.14.   New England Biolabs

8.3.15.   OriGene Technologies, Inc.

8.3.16.   Transposagen Biopharmaceuticals, Inc

//

Please note that currency denotation (USD Billion/Million) is provided on the basis of preliminary study, this may change in the final deliverables. Further, shipment values are subject to data availability.

//

 

 

The research for global CRISPR market focuses deeply on the entire value chain of the market. However, the market numbers are calculated purely based on the end user side of the value chain wherein the market sizes has been calculated by assuming the investments and development across various end user segments such as research & development institutes, biotechnology companies, pharmaceutical companies, academic institutions. Some key data points considered to calculate the revenue for global CRISPR market includes:

  • Rising prevalence of genetic disorders
  • Increasing geriatric population
  • R&D investments in CRISPR technologies across countries
  • Regulatory compliance for adoption of CRISPR technology
  • Revenue generated by companies in different geographies

Each of our research reports, go through an extensive process of primary and secondary research. Various government websites/portals and paid data sources are considered as key source of secondary research. Our team of analysts conduct extensive primary research across key industry people, through questionnaires, telephonic conversations, email conversations, and interviews.


We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

Full Name*

Business Email* (Please avoid generic email IDs such as gmail, yahoo)

Phone* (Please Affix Country Code)

Need specific market information? To get a customized report, please share your exact research requirements.

Buy Now


Single User – $3,950

Enterprise License – $5,550

Loading…